Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Hodgkin lymphoma Non-Hodgkin lymphoma

A. Thomas Look

Discovery of New Targets and Pathways for T-ALL Therapy

Leukaemia

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Leukaemia

Hematology and hematologic malignancies Pathology

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Wilburn E. Reddick

ALL therapy and developing brains: MRI measures, genetic factors and cognition

Leukaemia

Pediatric oncology or childhood cancer

Alejandro Gutierrez

Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL

Leukaemia

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia

Hematology and hematologic malignancies Pathology

Aude Chapuis

Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W

Leukaemia

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia